HCAR1 and neoplasm: Interestingly, interleukin-6 (IL-6)/STAT3 signaling has also been implicated in EMT within tumor-infiltrating myeloid cells (TIMs), CAFs, and tumor-associated adipocytes [53–55], suggesting that STAT3/IL-6 pathways may jointly participate in GPR81-mediated EMT.